Form 8-K - Current report:
SEC Accession No. 0001193125-16-747326
Filing Date
2016-10-26
Accepted
2016-10-26 08:31:57
Documents
15
Period of Report
2016-10-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d255045d8k.htm 8-K 15440
2 EX-99.1 d255045dex991.htm EX-99.1 16933
3 EX-99.2 d255045dex992.htm EX-99.2 11250
4 GRAPHIC g255045ex99_2s10g1.jpg GRAPHIC 81825
5 GRAPHIC g255045ex99_2s11g1.jpg GRAPHIC 316623
6 GRAPHIC g255045ex99_2s1g1.jpg GRAPHIC 375830
7 GRAPHIC g255045ex99_2s2g1.jpg GRAPHIC 581393
8 GRAPHIC g255045ex99_2s3g1.jpg GRAPHIC 315881
9 GRAPHIC g255045ex99_2s4g1.jpg GRAPHIC 132518
10 GRAPHIC g255045ex99_2s5g1.jpg GRAPHIC 211272
11 GRAPHIC g255045ex99_2s6g1.jpg GRAPHIC 202814
12 GRAPHIC g255045ex99_2s7g1.jpg GRAPHIC 209123
13 GRAPHIC g255045ex99_2s8g1.jpg GRAPHIC 197985
14 GRAPHIC g255045ex99_2s9g1.jpg GRAPHIC 202515
15 GRAPHIC g255045g23a41.jpg GRAPHIC 51578
  Complete submission text file 0001193125-16-747326.txt   4012013
Mailing Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

EIN.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36517 | Film No.: 161951599
SIC: 2834 Pharmaceutical Preparations